Caribou Biosciences Inc (CRBU NASDAQ) stock market data APIs
$1.8688
0.02(1.1%)
as of December 11, 2025
Try our APIs with
free plan!
Caribou Biosciences Inc Financial Data Overview
Price chart is built with
Anychart
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally. The company's lead product candidate include CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma, refractory systemic lupus erythematosus, lupus nephritis, and extrarenal lupus. It also develops CB-011, an anti-BCMA allogeneic CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma; and CB-012, an allogeneic anti-CD371 CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
Prev. Close
1.8688
Open
1.8888
High
1.9071
Low
1.8344
52 wk Range
0.66-3.535
Market Cap
174 M
Shares Outstanding
93 468 K
Revenue
9 295 K
EPS
-0.3
Beta
2.604
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Caribou Biosciences Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Caribou Biosciences Inc data using free add-ons & libraries
Get Caribou Biosciences Inc Fundamental Data
Caribou Biosciences Inc Fundamental data includes:
- Net Revenue: 9 295 K
- EBITDA: -135 692 992
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-13
- EPS/Forecast: -0.35
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Caribou Biosciences Inc News
New
Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025
KOL panel to discuss how vispa-cel, an anti-CD19 allogeneic CAR-T cell therapy, can broaden access for patients with second-line large B cell lymphoma including through use in the community setting B...
Caribou Bioscience GAAP EPS of -$0.30 beats by $0.07, revenue of $2.2M misses by $0.07M
* Caribou Bioscience press release [https://seekingalpha.com/pr/20305067-caribou-biosciences-reports-third-quarter-2025-financial-results-and-provides-business-update] (CRBU [https://seekingalpha.co...
Pre-Market Most Active for Nov 3, 2025 : CRBU, CURR, KVUE, CIFR, IREN, BITF, TSLL, FUBO, BMY, PFE, HKD, PCG
The NASDAQ 100 Pre-Market Indicator is up 190.14 to 26,048.27. The total Pre-Market volume is currently 273,604,382 shares traded. The following are the most active stocks for the pre-market sessi...
Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma
First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory multiple myeloma 450 million cell dose is the recommended...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
